Abiopharma

News list

(90% Positive) AERIE PHARMACEUTICALS INC (AERI) Provides Update on responsibility for Aerie shares

Full text

News bot Oct. 2, 2025, 5:15 a.m.
📋 AERIE PHARMACEUTICALS INC (AERI) - Clinical Trial Update

Filing Date: 2022-06-08

Accepted: 2022-06-08 07:31:02

Event Type: Clinical Trial Update
Event Details:
Aerie Pharmaceuticals Inc (the company is taken over Alcon (ALC)) (AERI) Announces Clinical Trial Update Aerie Pharmaceuticals Inc (the company is taken over Alcon (ALC)) (AERI) provided an update on its clinical development programs. Clinical Development Highlights:
Drug Program: responsibility, change
Diseases/Conditions: Aerie shares
Collaboration: Aerie Pharmaceuticals, Inc.
Targeting a Q4:2022
targeting 12-month dosing • Potential for lowest dosing interval of any product in development 1) Market Scope Reference is the 2021
expected in 2023
💼 Business Developments:
- Partnership
- Acquisition: Not available
- Licensing: Not available
- Regulatory Approval
- Executive Changes: Not available
Structured Data:
- Company Name: Aerie Pharmaceuticals Inc (the company is taken over Alcon (ALC))
- CIK: 0001337553
- Ticker Symbol: AERI
- Period End Date: 2022-06-08
- Document Type: 8-K